InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-16 · accession 0001209191-22-030067 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-05-18 2022-05-16 PCVX PICKERING GRANT CEO, Dir S - Sale+OE $23.91 -11.0K 703.9K -2% -$263.0K
D 2022-05-18 2022-05-16 PCVX PICKERING GRANT CEO, Dir M - OptEx $1.79 +11.0K 714.9K +2% +$19.7K
D 2022-05-18 2022-05-16 PCVX PICKERING GRANT CEO, Dir M - OptEx $0.00 -11.0K 234.4K -4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-16 S D 7,866 $23.76 707,028 D — — (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $23.17 to $24.16. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2022-05-16 M A 11,000 $1.79 714,894 D — —
3 Common Common Stock 2022-05-16 S D 3,134 $24.28 703,894 D — — (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $24.17 to $24.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (right to buy) 2022-05-16 M D 11,000 $0.00 234,450 D $1.79 · — to 2027-05-17 11,000 Common Stock (F4) The shares subject to the option are fully vested and exercisable.